OUS Researcher Awards 2023 Excellent researcher awards to Halvorsen, Kryeziu and Skjerven

From left: Kryeziu, Halvorsen and Skjerven
From left: Kryeziu, Halvorsen and Skjerven

Three Oslo University Hospital scientists received prestigous awards for their outstanding research on Friday June 9th.
The major prize - the "Excellent Researcher Award" - went to Bente Halvorsen. Kushtrim Kryeziu and Håvard O. Skjerven both received the "Early Career Award".
The prize money - 300.000 and 150.000 NOK respectively - is earmarked for research activities.

The awards are distributed anually in order to honour excellent scientific work. The awarding process is organized by the hospital's research committee, while an external Scientific Advisory Board has evaluated the candidates. 

PhD defences on transcriptomics of colorectal cancer and molecular pathology of prostate cancer

Over the past week, two PhD candidates from the Department of Molecular Oncology successfully defended their theses at the Faculty of Medicine, University of Oslo.

On June 2nd, M.D. Mari Bogaard presented her PhD thesis titled "On the hunt for improved biomarkers in primary prostate cancer – combining morphological features and molecular changes".

One week earlier, on May 26th, M.Sc. S. Hossein Moosavi defended his thesis on the "Clinical implications of transcriptomic and pharmacological tumor heterogeneity of metastatic colorectal cancers".

Researcher-of-the-year 2022 at the Institute for Cancer Research: Kushtrim Kryeziu

Kushtrim Kryeziu
Kushtrim Kryeziu

Kushtrim Kryeziu is 37 years and defended his PhD at the Medical University of Vienna in 2016. Kryeziu was recruited to the Lothe lab in 2016 via an EU financed fellowship and was included in the Scientia Fellows postdoc program at the University of Oslo. His recruitment has proven highly beneficial for the development of the current project on functional oncology in advanced solid tumors. His competence in molecular cell biology and hands-on experience with anti-cancer drug development was instrumental to the development of our pre-clinical pharmacogenomics platform. Kryeziu has recently accepted a permanent position at the Institute for Cancer Research. 

Four PhDs defended in 2022 from members of Molecular Oncology

Ina A. Eilertsen and Christian Holst Bergsland defended their respective work in transcriptomics and molecular pathology of colorectal cancer, Maren Høland recently defended her work on genomics of Malignant peripheral nerve sheath tumors, and Jonas Meier Strømme defended his computational analyses in solid tumors last week, 9th Dec. Their PhD theses comprise a total of thirteen papers from our groups, including eleven first-authorships among the PhD candidates.

Pharmacogenomics to improve transplantation oncology of metastatic colorectal cancer

Anita Sveen and Pål-Dag Line
Anita Sveen and Pål-Dag Line

Molecular biologist Anita Sveen and surgeon Pål-Dag Line join forces in a new project to improve the patient benefit from liver transplantation of metastatic colorectal cancer. This is a collaborative effort between Dept Molecular Oncology (KRE) and Dept Transplantation Medicine (KIT)

The project is a translational substudy of ongoing clinical studies and will generate the first large-scale molecular and pharmacological data of transplantable metastatic colorectal cancers. This project was recently supported by a research grant from the Norwegian Cancer Society.

Anita Sveen invited speaker at AACR special conference on colorectal cancer

Anita Sveen
Anita Sveen

Anita Sveen, project group leader and member of the Lothe lab at the Department of Molecular Oncology at the Institute for Cancer research, was invited speaker at the AACR special conference colorectal cancer, held October 1-4th in Portland, Oregon, USA.
In her well received speech Dr. Sveen presented the multidisciplinary work from the TEAM-ACT (Tumor Evolution in Advanced Models to Accelerate precision Cancer Therapy) - a strategic research area of OUS. 

Christian Holst Bergsland defended his doctoral thesis

On the 21st of April, the 4x-great-grandchild of Frederik Holst - the first who defended a doctoral thesis in Norway, University of Christiania - Christian Holst Bergsland defended his thesis “Fluorescence-based multiplex immunohistochemistry in precision medicine of colorectal cancer” for the PhD degree at the Faculty of Medicine, University of Oslo.
He received excellent assessment from the committee, both in the written report and during the defense. The first and second opponents were Professors Manuel Salto-Tellez, Institute for Cancer Research, London and Lars Akslen, University of Bergen. Professor Anne Hansen Ree was the chair of the evaluation committee.

Feb 2022Nov 2021Oct 2021Sep 2021Aug 2021Dec 2020Sep 2020Aug 2020Apr 2020Feb 2020Dec 2019Nov 2019Sep 2019Aug 2019Jun 2019Oct 2018Jun 2018Mar 2018Jan 2018Nov 2017Aug 2017Jun 2017Apr 2017Aug 2016Jun 2016Mar 2016Feb 2016Dec 2015Nov 2015Sep 2015Aug 2015Jun 2015May 2015Feb 2015Dec 2014Nov 2014Sep 2014Jul 2014May 2014Apr 2014Dec 2013Nov 2013Sep 2013May 2013Apr 2013Oct 2012Aug 2012Mar 2012Feb 2012Jan 2012Nov 2011Jun 2011May 2011Apr 2011Dec 2010Nov 2010Jun 2010May 2010Mar 2010Feb 2010Nov 2009Jun 2009May 2009Jan 2009